Harbor Advisors LLC Takes $203,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Harbor Advisors LLC purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) during the third quarter, HoldingsChannel.com reports. The fund purchased 500 shares of the company’s stock, valued at approximately $203,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Hilltop Holdings Inc. purchased a new position in HCA Healthcare in the 3rd quarter worth about $209,000. Holocene Advisors LP lifted its stake in HCA Healthcare by 210.6% in the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after purchasing an additional 208,015 shares during the last quarter. Centiva Capital LP increased its holdings in shares of HCA Healthcare by 37.4% during the third quarter. Centiva Capital LP now owns 13,264 shares of the company’s stock valued at $5,391,000 after acquiring an additional 3,612 shares in the last quarter. Edgestream Partners L.P. purchased a new position in HCA Healthcare in the 3rd quarter worth $8,183,000. Finally, Caisse DE Depot ET Placement DU Quebec increased its holdings in HCA Healthcare by 53.5% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 304,819 shares of the company’s stock valued at $123,888,000 after buying an additional 106,246 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.1 %

Shares of NYSE:HCA opened at $327.62 on Tuesday. The stock’s 50-day moving average is $371.88 and its 200-day moving average is $358.84. HCA Healthcare, Inc. has a 52-week low of $250.67 and a 52-week high of $417.14. The company has a market cap of $82.99 billion, a P/E ratio of 14.71, a P/E/G ratio of 1.26 and a beta of 1.63. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.81%. HCA Healthcare’s dividend payout ratio is 11.85%.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Morgan Stanley initiated coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective for the company. TD Cowen decreased their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Royal Bank of Canada raised their price target on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Finally, Oppenheimer boosted their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $380.29.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. This trade represents a 21.97 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock valued at $5,608,990 in the last 90 days. 1.70% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.